FDA is using ‘a sword to killa mosquito’, exercise power with restraint: Bombay HC

The Bombay High Court on Tuesday directed the Maharashtra Food and Drug Administration (FDA) to grant a hearing to pharmaceutical companies before taking action against their products, observing that the regulator was using “a sword to kill a mosquito”.A Division Bench of Acting Chief Justice Ravindra Ghuge and Justice Gautam Ankhad made the observation while hearing a plea filed by Cadila Pharmaceuticals Limited challenging the FDA’s decision to bar the sale and distribution of some of its medicines and seize stock worth ₹2.45 crore across the State over branding similarities.It accepted the statement of government pleader Neha Bhide that the FDA would revoke its orders against the petitioner, issue show-cause notices, and grant a hearing before passing a reasoned order.Warns of imposing